Top Markets
Coin of the day
Aarti Pharmalabs Limited Aarti Pharmalabs Limited

Aarti Pharmalabs Limited

AARTIPHARM
Rankning i aktier #10430
Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and... Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.
Aktiekurs
$9.28
Senast synkroniserad: 2026-08-28
Marknadsvärde
$841.31M
Förändring (1 dag)
3.34%
Förändring (1 år)
-2.77%
Land
IN
Handel Aarti Pharmalabs Limited (AARTIPHARM)

Kategori

Utdelningsavkastning för Aarti Pharmalabs Limited (AARTIPHARM)
Utdelningsavkastningen (TTM) för Aarti Pharmalabs Limited (aktiesymbol: AARTIPHARM) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för Aarti Pharmalabs Limited (AARTIPHARM) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter